The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons.
Matera C, Bono F, Pelucchi S, Collo G, Bontempi L, Gotti C, Zoli M, De Amici M, Missale C, Fiorentini C, Dallanoce C.
Matera C, et al. Among authors: de amici m.
Biochem Pharmacol. 2019 May;163:154-168. doi: 10.1016/j.bcp.2019.02.019. Epub 2019 Feb 14.
Biochem Pharmacol. 2019.
PMID: 30772268
Free article.